Cbg Expression

CBG expression refers to cannabis plants that produce elevated levels of cannabigerol (CBG), a non-intoxicating cannabinoid that serves as a biochemical precursor to THC, CBD, and CBC during plant development. Lineage records frequently report CBG-dominant phenotypes emerging from specific breeding crosses, particularly within African landraces and certain Sativa-leaning genetics. Breeders working in this category have documented that CBG levels typically range highest in immature plant material, declining as flowering progresses and cannabinoids convert to downstream compounds. The trait appears to have moderate heritability, though environmental factors—including harvest timing and growing conditions—significantly influence final cannabinoid ratios. CBG-expressing cultivars remain relatively uncommon in commercial seed catalogs compared to CBD or THC-focused lines.

Breeders targeting CBG expression typically select for early-harvest phenotypes or work with genetics showing naturally delayed cannabinoid conversion. Stabilizing CBG dominance presents unique challenges due to the compound's transient nature in the plant's biochemical pathway.